Medical Device News Magazine

George C. McFarland, MSW Joins Evon Medics, LLC as Advisor

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

George C. McFarland has joined the advisory board of Evon Medics, LLC in a formal advisory role.

Mr. McFarland is currently the President and CEO of McFarland & Associates, Inc. a management consulting firm established in Montgomery County, Maryland in 1989.

“Mr. McFarland’s network and experience working with numerous federal, state, and community organizations throughout the United States to improve the quality of life in communities affected by health and social determined risks would be valuable to Evon Medics as we continue to engage these underserved populations in our clinical trials,” said Charles Nwaokobia, Chief Operating Officer, Evon Medics, LLC. “We are also excited about the opportunity to leverage his wealth of experience managing over $100 million in grants and contracts to promote health and human development.”

George C. McFarland holds both BA and Master of Social Work degrees from Howard University with an emphasis on social policy, economics, and research. Over the past three decades McFarland & Associates, Inc. has served as both a prime contractor and subcontractor to many of the nation’s foremost research and service firms throughout the United States. He is a graduate of the United States Small Business Administration’s 8(a) Program designed to foster minority business ownership and growth.

McFarland is a graduate of Leadership Maryland, a statewide leadership training Institute that brings together a collaboration of business leaders and practitioners to help solve problems unique to the state of Maryland. For more than 25 years Mr. McFarland has served on the Board of Directors for So Others Might Eat, a local homeless organization that provides shelter, food, education, and training to more than 13,000 residents of the District of Columbia annually.

Evon Medics, LLC is a medical devices and neuroscience research company founded in April 2013 by Johns Hopkins trained physicians. The company develops therapeutics and devices for the treatment of Alzheimer’s Disease, Opioid Use Disorder, Traumatic Brain Injury, Chronic pain, and other chronic neurological diseases that have remained elusive to treatment. The company Head Office is in Elkridge, Maryland.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”